{"news_desk": "Foreign", "print_page": "9", "section_name": "World", "subsection_name": "Africa", "byline": {"contributor": "", "original": "By REUTERS", "person": [], "organization": "REUTERS"}, "abstract": "Two Ebola vaccines being tested on more than 600 volunteers in Liberia pass initial safety tests.", "type_of_material": "Brief", "word_count": "86", "lead_paragraph": "Two experimental Ebola vaccines \u201cappear to be safe\u201d partway through a clinical trial being conducted in Liberia, the National Institutes of Health said Thursday.", "pub_date": "2015-03-27T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Ebola Vaccines Pass Initial Safety Tests", "content_kicker": "World Briefing", "print_headline": "Science and Health; Ebola Vaccines Pass Initial Safety Tests"}, "snippet": "Two experimental Ebola vaccines \u201cappear to be safe\u201d partway through a clinical trial being conducted in Liberia, the National Institutes of Health said Thursday.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/03/27/world/africa/ebola-vaccines-pass-initial-safety-tests.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Ebola Virus", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Vaccination and Immunization", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Liberia", "name": "glocations"}, {"rank": "4", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "GlaxoSmithKline PLC", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "NewLink Genetics Corporation", "name": "organizations"}], "blog": [], "_id": "5514d52138f0d82942dd61d3", "source": "The New York Times"}